Skip to content

Construction and Application of Blood Glucose Management Protocol for Non-Dialysis Patients with Diabetic Kidney Disease Based on the Triangle Hierarchical Model

Construction and Application of Blood Glucose Management Protocol for Non-Dialysis Patients with Diabetic Kidney Disease Based on the Triangle Hierarchical Model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126984
Enrollment
Unknown
Registered
2026-06-22
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus with Diabetic Kidney Disease (non-dialysis stage, G1–G4)

Interventions

Trial Group:Triangle stratified glycemic management intervention
Control Group:Usual diabetes nursing care and health education
Expert Interview Group:None

Sponsors

Nanjing Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Part II: Criteria for selecting experts for consultation: 1. Experts and scholars whose research fields include endocrinology, nephrology, geriatrics, nursing quality management, evidence-based practice, nutrition, and related areas; 2. Familiar with the content of this research topic; 3. Hold a bachelor’s degree or above; 4. Hold an associate senior professional title or above; 5. Voluntarily participate in this study. Part III: 1. Meet the diagnostic criteria for diabetic kidney disease, with GA staging at G1–G4. 2. Age >= 18 years. 3. Clear consciousness and normal cognitive and behavioral abilities. 4. Provide informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients in the GA stage who have undergone dialysis during the G5 stage or within the past month. 2. Patients with a history of malignant tumors. 3. Patients who have developed acute complications such as diabetic ketoacidosis or hyperosmolar coma. 4. Patients with mental illness or impaired cognitive and behavioral functioning. 5. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Fasting Blood Glucose,FBG;Glycated Hemoglobin, HbA1c;2-hour postprandial glucose,2hPG;

Secondary

MeasureTime frame
Diabetes-specific Quality of Life,DQoL;Serum Potassium Concentration,K?;Urine albumin-to-creatinine ratio, UACR;Hospitalization rate and emergency department visit rate;Diabetes self-management ability;Estimated glomerular filtration rate, eGFR;Serum Chloride Concentration,Cl?;Serum Sodium Concentration,Na?;Incidence of acute and chronic complications;

Countries

China

Contacts

Public ContactLi Jianhua

Nanjing Central Hospital

654042828@qq.com+86 25 68781605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026